Global Biliary Atresia Treatment Market, by Disease Type (Type I, Type II, and Type III), by Treatment Type (Medications (Bile Acids, Antibiotics, and Corticosteroids) and Surgery), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 910.7 Mn in 2021 and is expected to exhibit a CAGR of 7.7% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Increasing research to develop safe and effective drugs for biliary atresia is expected to propel the growth of the global biliary atresia treatment market over the forecast period. For instance, as of October 2021, Odevixibat, a selective inhibitor of ileal bile acid transporter (IBAT), is undergoing a double-blind, randomized, placebo-controlled, phase III study to investigate its efficacy in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy.
Global Biliary Atresia Treatment Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic has highly impacted research and clinical trials of biliary atresia. They have been highly impacted due to the lack of new sample collections.
Moreover, according to an article published by American Association for the Study of Liver Diseases, substantial decrease in donations with unprecedented financial challenges and the cancellation of all fundraising events, will certainly impact pediatric liver research funding
On a positive note, the COVID-19 pandemic has strengthened the pediatric hepatology community. For instance, The Society of Pediatric Liver Transplantation–The Transplantation Society and North American Society for Pediatric Gastroenterology, Hepatology & Nutrition has established a joint national registry for COVID-19 in kids with post–liver transplantation and chronic liver disease.
Browse 28 Market Data Tables and 24 Figures spread through 191 Pages and in-depth TOC on “Global Biliary Atresia Treatment Market”- Forecast to 2028, Global Biliary Atresia Treatment Market, by Disease Type (Type I, Type II, and Type III), by Treatment Type (Medications (Bile Acids, Antibiotics, and Corticosteroids) and Surgery), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
Moreover, efforts undertaken by organizations to design and carry out studies on rare diseases are also expected to aid in the growth of the global biliary atresia treatment market over the forecast period. For instance, ‘The Childhood Liver Disease Research Network’ (ChiLDReN) is a collaborative team of doctors, nurses, medical facilities, research coordinators, and patient support organizations. Moreover, the network aims to improve the lives of youngsters and families dealing with rare liver diseases. The ChiLDReN Network was formed in October 2019, to support the invention of the latest diagnostic, etiologic, treatment options for children with liver disease, and people who undergo liver transplantation.
Key Takeaways of the Global Biliary Atresia Treatment Market:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.